Company · CIK 0001003642 · SIC 2834 — Pharmaceutical Preparations
Impax Laboratories, LLC · IPXL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 4, 2018 DForm 4 → | May 8, 4:30 pm EDT | Janet S. VergisDirector | 12,150 | — | — | 0 | — | plan? |
| May 4, 2018 DForm 4 → | May 8, 4:27 pm EDT | Peter R TerreriDirector | 48,537 | — | — | 0 | — | plan? |
| May 4, 2018 DForm 4 → | May 8, 4:25 pm EDT | Mary K PendergastDirector | 22,350 | — | — | 0 | — | plan? |
| May 4, 2018 DForm 4 → | May 8, 4:24 pm EDT | Allen ChaoDirector | 385,445 | — | — | 0 | — | plan? |
| May 4, 2018 DForm 4 → | May 8, 4:23 pm EDT | J Kevin BuchiDirector | 11,301 | — | — | 0 | — | plan? |
| May 4, 2018 DForm 4 → | May 8, 4:20 pm EDT | Leslie Z BenetDirector | 23,083 | — | — | 0 | — | plan? |
| May 4, 2018 DForm 4 → | May 8, 4:19 pm EDT | Robert L BurrDirector | 66,532 | — | — | 0 | — | plan? |
| May 4, 2018 DForm 4 → | May 8, 4:16 pm EDT | Jeffrey NornholdSVP, Technical Operations | 65,878 | — | — | 0 | — | plan? |
| May 4, 2018 DForm 4 → | May 8, 4:16 pm EDT | Mark A SchlossbergSVP and General Counsel | 68,251 | — | — | 0 | — | plan? |
| May 4, 2018 DForm 4 → | May 8, 4:14 pm EDT | Michael NestorPresident, Impax Specialty | 76,524 | — | — | 0 | — | plan? |
| May 4, 2018 DForm 4 → | May 8, 4:13 pm EDT | Douglas BoothePresident, Generics Division | 55,901 | — | — | 0 | — | plan? |
| May 4, 2018 DForm 4 → | May 8, 4:08 pm EDT | Bryan M. ReasonsChief Financial Officer | 73,989 | — | — | 0 | — | plan? |
| Mar 2, 2018 FForm 4 → | Mar 5, 12:49 pm EST | Jeffrey NornholdSVP, Technical Operations | 2,436 | $19.50 | $47,502 | 79,582 | — | plan? |
| Mar 2, 2018 FForm 4 → | Mar 5, 12:48 pm EST | Douglas BoothePresident, Generics Division | 2,041 | $19.50 | $39,800 | 78,549 | — | plan? |
| Mar 2, 2018 FForm 4 → | Mar 5, 12:47 pm EST | Mark A SchlossbergSVP and General Counsel | 3,273 | $19.50 | $63,824 | 89,246 | — | plan? |
| Mar 2, 2018 FForm 4 → | Mar 5, 12:46 pm EST | Bryan M. ReasonsChief Financial Officer | 3,069 | $19.50 | $59,846 | 94,684 | — | plan? |
| Feb 26, 2018 FForm 4 → | Feb 27, 12:21 pm EST | Jeffrey NornholdSVP, Technical Operations | 4,215 | $20.95 | $88,304 | 82,018 | — | plan? |
| Feb 26, 2018 FForm 4 → | Feb 27, 12:20 pm EST | Michael NestorPresident, Impax Specialty | 5,547 | $20.95 | $116,210 | 101,396 | — | plan? |
| Feb 26, 2018 FForm 4 → | Feb 27, 12:19 pm EST | Bryan M. ReasonsChief Financial Officer | 6,141 | $20.95 | $128,654 | 97,753 | — | plan? |
| Feb 26, 2018 FForm 4 → | Feb 27, 12:18 pm EST | Mark A SchlossbergSVP and General Counsel | 5,937 | $20.95 | $124,380 | 92,519 | — | plan? |
| Oct 25, 2017 FForm 4 → | Oct 26, 1:08 pm EDT | Jeffrey NornholdSVP, Technical Operations | 2,734 | $19.60 | $53,586 | 86,233 | — | plan? |
| Aug 1, 2017 FForm 4 → | Aug 2, 9:15 am EDT | Douglas BoothePresident, Generics Division | 5,282 | $17.85 | $94,284 | 80,590 | — | plan? |
| May 31, 2017 SForm 4 → | Jun 1, 2:36 pm EDT | Michael NestorPresident, Impax Specialty | 1,130 | $15.00 | $16,950 | 106,943 | −1.05% | plan? |
| May 17, 2017 SForm 4 → | May 17, 3:52 pm EDT | Michael NestorPresident, Impax Specialty | 857 | $16.48 | $14,119 | 108,073 | −0.79% | plan? |
| May 16, 2017 AForm 4 → | May 17, 3:51 pm EDT | Peter R TerreriDirector | 4,375 | — | — | 48,537 | — | plan? |
| May 16, 2017 AForm 4 → | May 17, 3:50 pm EDT | J Kevin BuchiDirector | 3,281 | — | — | 11,301 | — | plan? |
| May 16, 2017 AForm 4 → | May 17, 3:50 pm EDT | Leslie Z BenetDirector | 4,375 | — | — | 22,483 | — | plan? |
| May 16, 2017 AForm 4 → | May 17, 3:49 pm EDT | Mary K PendergastDirector | 4,375 | — | — | 22,350 | — | plan? |
| May 16, 2017 AForm 4 → | May 17, 3:48 pm EDT | Allen ChaoDirector | 4,375 | — | — | 69,445 | — | plan? |
| May 16, 2017 AForm 4 → | May 17, 3:47 pm EDT | Rick BierlyDirector | 4,375 | — | — | 9,270 | — | plan? |
| May 16, 2017 AForm 4 → | May 17, 3:46 pm EDT | Janet S. VergisDirector | 4,375 | — | — | 12,150 | — | plan? |
| May 16, 2017 AForm 4 → | May 17, 3:46 pm EDT | Robert L BurrDirector | 4,375 | — | — | 60,475 | — | plan? |
| May 15, 2017 FForm 4 → | May 16, 2:55 pm EDT | Michael NestorPresident, Impax Specialty | 3,236 | $16.80 | $54,365 | 108,930 | — | plan? |
| May 14, 2017 FForm 4 → | May 16, 2:58 pm EDT | Jeffrey NornholdSVP, Technical Operations | 502 | $17.65 | $8,860 | 88,967 | — | plan? |
| May 14, 2017 FForm 4 → | May 16, 2:56 pm EDT | Mark A SchlossbergSVP and General Counsel | 6,723 | $17.21 | $115,696 | 98,456 | — | plan? |
| May 14, 2017 FForm 4 → | May 16, 2:54 pm EDT | Bryan M. ReasonsChief Financial Officer | 1,159 | $17.32 | $20,070 | 103,894 | — | plan? |
| May 14, 2017 FForm 4 → | May 15, 7:26 pm EDT | Michael NestorPresident, Impax Specialty | 3,002 | $17.65 | $52,985 | 112,166 | — | plan? |
| May 12, 2017 SForm 4 → | May 15, 7:26 pm EDT | Michael NestorPresident, Impax Specialty | 700 | $17.11 | $11,977 | 115,168 | −0.60% | plan? |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:12 pm EST | Jeffrey NornholdSVP, Technical Operations | 17,317 | — | — | 89,469 | — | plan? |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:11 pm EST | Michael NestorPresident, Impax Specialty | 23,272 | — | — | 115,868 | — | plan? |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:08 pm EST | Mark A SchlossbergSVP and General Counsel | 23,272 | — | — | 105,179 | — | plan? |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:08 pm EST | Bryan M. ReasonsChief Financial Officer | 23,272 | — | — | 105,053 | — | plan? |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:07 pm EST | Douglas BoothePresident, Generics Division | 23,272 | — | — | 85,872 | — | plan? |
| Feb 26, 2017 FForm 4 → | Feb 27, 8:23 pm EST | Bryan M. ReasonsChief Financial Officer | 5,715 | $14.05 | $80,296 | 81,781 | — | plan? |
| Feb 26, 2017 FForm 4 → | Feb 27, 8:22 pm EST | Mark A SchlossbergSVP and General Counsel | 6,014 | $14.05 | $84,497 | 81,907 | — | plan? |
| Feb 26, 2017 FForm 4 → | Feb 27, 8:20 pm EST | Michael NestorPresident, Impax Specialty | 5,594 | $14.05 | $78,596 | 92,596 | — | plan? |
| Feb 26, 2017 FForm 4 → | Feb 27, 8:16 pm EST | Jeffrey NornholdSVP, Technical Operations | 4,301 | $14.05 | $60,429 | 72,152 | — | plan? |
| Nov 23, 2016 AForm 4 → | Nov 28, 4:52 pm EST | J Kevin BuchiDirector | 8,020 | — | — | 8,020 | — | plan? |
| Oct 26, 2016 FForm 4 → | Oct 27, 12:05 pm EDT | Bryan M. ReasonsChief Financial Officer | 1,209 | $21.35 | $25,812 | 87,496 | — | plan? |
| Oct 25, 2016 FForm 4 → | Oct 27, 12:14 pm EDT | Jeffrey NornholdSVP, Technical Operations | 3,523 | $21.58 | $76,039 | 76,453 | — | plan? |
| Aug 30, 2016 AForm 4 → | Aug 31, 2:49 pm EDT | Douglas BoothePresident, Generics Division | 62,600 | — | — | 62,600 | — | plan? |
| Aug 24, 2016 GForm 4 → | Aug 29, 4:40 pm EDT | Leslie Z BenetDirector | 12,025 | — | — | 18,108 | — | plan? late |
| Aug 19, 2016 AForm 4 → | Aug 22, 4:38 pm EDT | Rick BierlyDirector | 4,895 | — | — | 4,895 | — | plan? |
| Aug 15, 2016 SForm 4 → | Aug 17, 3:46 pm EDT | Leslie Z BenetDirector | 10,092 | $22.81 | $230,199 | 30,133 | −25.1% | plan? |
| Aug 15, 2016 MForm 4 → | Aug 17, 3:46 pm EDT | Leslie Z BenetDirector | 20,000 | $6.55 | $131,000 | 40,225 | — | plan? |
| Aug 15, 2016 JForm 4 → | Aug 17, 3:42 pm EDT | Michael NestorPresident, Impax Specialty | 24,906 | — | — | 98,190 | — | plan? |
| May 23, 2016 FForm 4 → | May 24, 1:19 pm EDT | Michael NestorPresident, Impax Pharm. | 1,696 | $32.12 | $54,476 | 123,096 | — | plan? |
| May 23, 2016 FForm 4 → | May 24, 1:19 pm EDT | Mark A SchlossbergSVP and General Counsel | 1,095 | $32.12 | $35,171 | 87,921 | — | plan? |
| May 17, 2016 AForm 4 → | May 19, 11:01 am EDT | Robert L BurrDirector | 4,375 | — | — | 56,100 | — | plan? |
| May 17, 2016 AForm 4 → | May 19, 11:00 am EDT | Leslie Z BenetDirector | 4,375 | — | — | 20,225 | — | plan? |
| May 17, 2016 AForm 4 → | May 19, 10:59 am EDT | Allen ChaoDirector | 4,375 | — | — | 65,070 | — | plan? |
| May 17, 2016 AForm 4 → | May 19, 10:58 am EDT | Mary K PendergastDirector | 4,375 | — | — | 17,975 | — | plan? |
| May 17, 2016 AForm 4 → | May 19, 10:57 am EDT | Peter R TerreriDirector | 4,375 | — | — | 44,162 | — | plan? |
| May 17, 2016 AForm 4 → | May 19, 10:57 am EDT | Janet S. VergisDirector | 4,375 | — | — | 7,775 | — | plan? |
| May 14, 2016 FForm 4 → | May 16, 3:42 pm EDT | Bryan M. ReasonsChief Financial Officer | 3,105 | $29.18 | $90,604 | 88,705 | — | plan? |
| May 14, 2016 FForm 4 → | May 16, 3:42 pm EDT | Mark A SchlossbergSVP and General Counsel | 4,493 | $29.18 | $131,106 | 89,016 | — | plan? |
| May 14, 2016 FForm 4 → | May 16, 3:41 pm EDT | Jeffrey NornholdSVP, Technical Operations | 337 | $29.18 | $9,834 | 79,976 | — | plan? |
| May 14, 2016 FForm 4 → | May 16, 3:41 pm EDT | Michael NestorPresident, Impax Pharm. | 6,239 | $29.18 | $182,054 | 124,792 | — | plan? |
| Apr 29, 2016 FForm 4/A → | Dec 23, 2:34 pm EST | George Fred WilkinsonChief Executive Officer, Director | 97,219 | $33.35 | $3,242,254 | 429,237 | — | plan? |
| Apr 29, 2016 FForm 4 → | May 2, 12:45 pm EDT | George Fred WilkinsonChief Executive Officer, Director | 61,594 | $33.35 | $2,054,160 | 464,862 | — | plan? |
| Apr 13, 2016 FForm 4 → | Apr 14, 1:01 pm EDT | Bryan M. ReasonsChief Financial Officer | 1,035 | $35.35 | $36,587 | 91,810 | — | plan? |
| Mar 14, 2016 MForm 4 → | Mar 15, 2:04 pm EDT | Leslie Z BenetDirector | 3,500 | $6.55 | $22,925 | 15,850 | — | plan? |
| Feb 26, 2016 AFForm 4 → | Mar 1, 4:14 pm EST | Mark A SchlossbergSVP and General Counsel | 23,783 | $33.27 | $64,244 | 93,509 | — | plan? |
| Feb 26, 2016 AFForm 4 → | Mar 1, 4:13 pm EST | Bryan M. ReasonsChief Financial Officer | 28,071 | $33.27 | $65,143 | 92,845 | — | plan? |
| Feb 26, 2016 AFForm 4 → | Mar 1, 4:10 pm EST | George Fred WilkinsonChief Executive Officer, Director | 94,899 | $33.27 | $185,214 | 526,456 | — | plan? |
| Feb 26, 2016 AFForm 4 → | Mar 1, 4:09 pm EST | Michael NestorPresident, Impax Pharm. | 24,506 | $33.27 | $88,299 | 131,031 | — | plan? |
| Feb 26, 2016 AFForm 4 → | Mar 1, 4:07 pm EST | Jeffrey NornholdSVP, Technical Operations | 18,521 | $33.27 | $40,057 | 80,313 | — | plan? |
| Oct 29, 2015 FForm 4 → | Oct 30, 2:06 pm EDT | George Fred WilkinsonChief Executive Officer, Director | 16,425 | $35.75 | $587,194 | 442,691 | — | plan? |
| Oct 28, 2015 FForm 4 → | Oct 30, 2:03 pm EDT | Jeffrey NornholdSVP, Technical Operations | 1,271 | $36.94 | $46,951 | 64,200 | — | plan? |
| Oct 26, 2015 FForm 4 → | Oct 27, 12:46 pm EDT | Bryan M. ReasonsChief Financial Officer | 1,299 | $35.97 | $46,725 | 68,690 | — | plan? |
| Oct 25, 2015 FForm 4 → | Oct 27, 1:00 pm EDT | Jeffrey NornholdSVP, Technical Operations | 4,887 | $35.79 | $174,922 | 65,471 | — | plan? |
| Oct 7, 2015 AForm 4 → | Oct 9, 5:03 pm EDT | Janet S. VergisDirector | 3,400 | — | — | 3,400 | — | plan? |
| Sep 11, 2015 SForm 4 → | Sep 14, 7:13 pm EDT | Mark A SchlossbergSVP and General Counsel | 7,457 | $43.30 | $322,888 | 73,588 | −9.20% | plan? |
| Sep 10, 2015 SForm 4 → | Sep 14, 7:17 pm EDT | Michael NestorPresident, Impax Pharm. | 5,000 | $43.56 | $217,800 | 111,833 | −4.28% | plan? |
| Sep 8, 2015 GForm 4 → | Sep 14, 7:25 pm EDT | Leslie Z BenetDirector | 5,850 | — | — | 12,350 | — | plan? late |
| Sep 1, 2015 MForm 4 → | Sep 2, 6:39 pm EDT | Leslie Z BenetDirector | 9,000 | $6.55 | $58,950 | 18,200 | — | plan? |
| Aug 31, 2015 SForm 4 → | Sep 1, 7:23 pm EDT | Leslie Z BenetDirector | 20,000 | $40.92 | $818,400 | 9,200 | −68.5% | plan? |
| Aug 31, 2015 MForm 4 → | Sep 1, 7:23 pm EDT | Leslie Z BenetDirector | 20,000 | $21.73 | $434,678 | 11,700 | — | plan? |
| Aug 31, 2015 MForm 4 → | Sep 1, 6:53 pm EDT | Nigel FlemingDirector | 23,000 | $19.63 | $451,420 | 13,200 | — | plan? |
| Aug 31, 2015 SForm 4 → | Sep 1, 6:53 pm EDT | Nigel FlemingDirector | 29,166 | $41.02 | $1,196,389 | 8,200 | −78.1% | plan? |
| Aug 28, 2015 SForm 4 → | Sep 1, 6:30 pm EDT | Michael MarkbreiterDirector | 28,000 | $41.70 | $1,167,640 | 8,200 | −77.3% | plan? |
| Aug 28, 2015 MForm 4 → | Sep 1, 6:30 pm EDT | Michael MarkbreiterDirector | 28,000 | $19.85 | $555,920 | 18,200 | — | plan? |
| Aug 27, 2015 SForm 4 → | Aug 27, 8:08 pm EDT | Mark A SchlossbergSVP and General Counsel | 4,649 | $43.41 | $201,813 | 81,045 | −5.43% | plan? |
| Aug 27, 2015 SForm 4 → | Aug 27, 8:04 pm EDT | Peter R TerreriDirector | 4,833 | $43.93 | $212,314 | 39,787 | −10.8% | plan? |
| Aug 26, 2015 MForm 4 → | Aug 27, 7:09 pm EDT | Michael MarkbreiterDirector | 10,000 | $6.55 | $65,500 | 18,200 | — | plan? |
| Aug 25, 2015 SForm 4 → | Aug 27, 7:09 pm EDT | Michael MarkbreiterDirector | 19,399 | $42.24 | $819,456 | 8,200 | −70.3% | plan? |
| Jul 8, 2015 FForm 4 → | Jul 9, 12:44 pm EDT | Mark A SchlossbergSVP and General Counsel | 3,916 | $45.99 | $180,097 | 85,694 | — | plan? |
| May 23, 2015 FForm 4 → | May 26, 12:26 pm EDT | Mark A SchlossbergSVP and General Counsel | 1,102 | $46.21 | $50,923 | 89,610 | — | plan? |
| May 23, 2015 FForm 4 → | May 26, 12:22 pm EDT | Michael NestorPresident, Impax Pharm. | 1,696 | $46.21 | $78,372 | 116,833 | — | plan? |
| May 15, 2015 FForm 4 → | May 19, 12:15 pm EDT | Mark A SchlossbergSVP and General Counsel | 2,330 | $44.44 | $103,545 | 90,712 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 4, 2018 DForm 4 → | May 8, 4:30 pm EDT | Janet S. VergisDirector | 29,250 | — | — | 0 | — | |
| May 4, 2018 DForm 4 → | May 8, 4:27 pm EDT | Peter R TerreriDirector | 126,950 | — | — | 0 | — | |
| May 4, 2018 DForm 4 → | May 8, 4:25 pm EDT | Mary K PendergastDirector | 51,950 | — | — | 0 | — | |
| May 4, 2018 DForm 4 → | May 8, 4:24 pm EDT | Allen ChaoDirector | 83,950 | — | — | 0 | — | |
| May 4, 2018 DForm 4 → | May 8, 4:23 pm EDT | J Kevin BuchiDirector | 28,376 | — | — | 0 | — | |
| May 4, 2018 DForm 4 → | May 8, 4:20 pm EDT | Leslie Z BenetDirector | 164,500 | — | — | 0 | — | |
| May 4, 2018 DForm 4 → | May 8, 4:19 pm EDT | Robert L BurrDirector | 111,950 | — | — | 0 | — | |
| May 4, 2018 DForm 4 → | May 8, 4:16 pm EDT | Jeffrey NornholdSVP, Technical Operations | 167,184 | — | — | 0 | — | |
| May 4, 2018 DForm 4 → | May 8, 4:16 pm EDT | Mark A SchlossbergSVP and General Counsel | 385,200 | — | — | 0 | — | |
| May 4, 2018 DForm 4 → | May 8, 4:14 pm EDT | Michael NestorPresident, Impax Specialty | 377,283 | — | — | 0 | — | |
| May 4, 2018 DForm 4 → | May 8, 4:13 pm EDT | Douglas BoothePresident, Generics Division | 106,732 | — | — | 0 | — | |
| May 4, 2018 DForm 4 → | May 8, 4:08 pm EDT | Bryan M. ReasonsChief Financial Officer | 273,827 | — | — | 0 | — | |
| May 4, 2018 DForm 4 → | May 8, 4:06 pm EDT | Paul BisaroPresident and CEO, Director | 850,000 | — | — | 0 | — | |
| May 16, 2017 AForm 4 → | May 17, 3:51 pm EDT | Peter R TerreriDirector | 10,575 | — | — | 10,575 | — | |
| May 16, 2017 AForm 4 → | May 17, 3:50 pm EDT | J Kevin BuchiDirector | 7,931 | — | — | 7,931 | — | |
| May 16, 2017 AForm 4 → | May 17, 3:50 pm EDT | Leslie Z BenetDirector | 10,575 | — | — | 10,575 | — | |
| May 16, 2017 AForm 4 → | May 17, 3:49 pm EDT | Mary K PendergastDirector | 10,575 | — | — | 10,575 | — | |
| May 16, 2017 AForm 4 → | May 17, 3:48 pm EDT | Allen ChaoDirector | 10,575 | — | — | 10,575 | — | |
| May 16, 2017 AForm 4 → | May 17, 3:47 pm EDT | Rick BierlyDirector | 10,575 | — | — | 10,575 | — | |
| May 16, 2017 AForm 4 → | May 17, 3:46 pm EDT | Janet S. VergisDirector | 10,575 | — | — | 10,575 | — | |
| May 16, 2017 AForm 4 → | May 17, 3:46 pm EDT | Robert L BurrDirector | 10,575 | — | — | 10,575 | — | |
| Mar 27, 2017 AForm 4 → | Mar 29, 6:20 pm EDT | Paul BisaroPresident and CEO, Director | 850,000 | — | — | 850,000 | — | |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:12 pm EST | Jeffrey NornholdSVP, Technical Operations | 41,842 | — | — | 41,842 | — | |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:11 pm EST | Michael NestorPresident, Impax Specialty | 56,232 | — | — | 56,232 | — | |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:08 pm EST | Mark A SchlossbergSVP and General Counsel | 56,232 | — | — | 56,232 | — | |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:08 pm EST | Bryan M. ReasonsChief Financial Officer | 56,232 | — | — | 56,232 | — | |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:07 pm EST | Douglas BoothePresident, Generics Division | 56,232 | — | — | 56,232 | — | |
| Nov 23, 2016 AForm 4 → | Nov 28, 4:52 pm EST | J Kevin BuchiDirector | 20,445 | — | — | 20,445 | — | |
| Aug 30, 2016 AForm 4 → | Aug 31, 2:49 pm EDT | Douglas BoothePresident, Generics Division | 50,500 | — | — | 50,500 | — | |
| Aug 19, 2016 AForm 4 → | Aug 22, 4:38 pm EDT | Rick BierlyDirector | 11,840 | — | — | 11,840 | — | |
| Aug 15, 2016 MForm 4 → | Aug 17, 3:46 pm EDT | Leslie Z BenetDirector | 20,000 | — | — | 30,000 | — | |
| May 17, 2016 AForm 4 → | May 19, 11:01 am EDT | Robert L BurrDirector | 10,575 | — | — | 10,575 | — | |
| May 17, 2016 AForm 4 → | May 19, 11:00 am EDT | Leslie Z BenetDirector | 10,575 | — | — | 10,575 | — | |
| May 17, 2016 AForm 4 → | May 19, 10:59 am EDT | Allen ChaoDirector | 10,575 | — | — | 10,575 | — | |
| May 17, 2016 AForm 4 → | May 19, 10:58 am EDT | Mary K PendergastDirector | 10,575 | — | — | 10,575 | — | |
| May 17, 2016 AForm 4 → | May 19, 10:57 am EDT | Peter R TerreriDirector | 10,575 | — | — | 10,575 | — | |
| May 17, 2016 AForm 4 → | May 19, 10:57 am EDT | Janet S. VergisDirector | 10,575 | — | — | 10,575 | — | |
| Mar 14, 2016 MForm 4 → | Mar 15, 2:04 pm EDT | Leslie Z BenetDirector | 3,500 | — | — | 50,000 | — | |
| Feb 26, 2016 AForm 4 → | Mar 1, 4:14 pm EST | Mark A SchlossbergSVP and General Counsel | 52,801 | — | — | 52,801 | — | |
| Feb 26, 2016 AForm 4 → | Mar 1, 4:13 pm EST | Bryan M. ReasonsChief Financial Officer | 63,095 | — | — | 63,095 | — | |
| Feb 26, 2016 AForm 4 → | Mar 1, 4:10 pm EST | George Fred WilkinsonChief Executive Officer, Director | 215,851 | — | — | 215,851 | — | |
| Feb 26, 2016 AForm 4 → | Mar 1, 4:09 pm EST | Michael NestorPresident, Impax Pharm. | 52,801 | — | — | 52,801 | — | |
| Feb 26, 2016 AForm 4 → | Mar 1, 4:07 pm EST | Jeffrey NornholdSVP, Technical Operations | 41,842 | — | — | 41,842 | — | |
| Oct 7, 2015 AForm 4 → | Oct 9, 5:03 pm EDT | Janet S. VergisDirector | 8,100 | — | — | 8,100 | — | |
| Sep 1, 2015 MForm 4 → | Sep 2, 6:39 pm EDT | Leslie Z BenetDirector | 9,000 | — | — | 53,500 | — | |
| Aug 31, 2015 MForm 4 → | Sep 1, 7:23 pm EDT | Leslie Z BenetDirector | 20,000 | — | — | 53,500 | — | |
| Aug 31, 2015 MForm 4 → | Sep 1, 6:53 pm EDT | Nigel FlemingDirector | 23,000 | — | — | 5,000 | — | |
| Aug 28, 2015 MForm 4 → | Sep 1, 6:30 pm EDT | Michael MarkbreiterDirector | 28,000 | — | — | 0 | — | |
| Aug 26, 2015 MForm 4 → | Aug 27, 7:09 pm EDT | Michael MarkbreiterDirector | 10,000 | — | — | 0 | — | |
| May 12, 2015 AForm 4 → | May 13, 9:04 pm EDT | Robert L BurrDirector | 7,300 | — | — | 7,300 | — | |
| May 12, 2015 AForm 4 → | May 13, 9:01 pm EDT | Allen ChaoDirector | 7,300 | — | — | 7,300 | — | |
| May 12, 2015 AForm 4 → | May 13, 8:56 pm EDT | Nigel FlemingDirector | 7,300 | — | — | 7,300 | — | |
| May 12, 2015 AForm 4 → | May 13, 8:50 pm EDT | Mary K PendergastDirector | 7,300 | — | — | 7,300 | — | |
| May 12, 2015 AForm 4 → | May 13, 8:47 pm EDT | Larry HsuDirector | 7,300 | — | — | 7,300 | — | |
| May 12, 2015 AForm 4 → | May 13, 8:40 pm EDT | Peter R TerreriDirector | 7,300 | — | — | 7,300 | — | |
| May 12, 2015 AForm 4 → | May 13, 8:36 pm EDT | Michael MarkbreiterDirector | 7,300 | — | — | 7,300 | — | |
| May 12, 2015 AForm 4 → | May 13, 8:32 pm EDT | Leslie Z BenetDirector | 12,000 | — | — | 12,000 | — | |
| Mar 25, 2015 MForm 4 → | Mar 27, 5:56 pm EDT | Larry HsuDirector | 73,500 | — | — | 0 | — | |
| Feb 26, 2015 AForm 4 → | Mar 12, 2:31 pm EDT | George Fred WilkinsonChief Executive Officer, Director | 162,000 | — | — | 162,000 | — | late |
| Feb 26, 2015 AForm 4 → | Mar 12, 2:27 pm EDT | Michael NestorPresident, Impax Pharm. | 47,500 | — | — | 47,500 | — | late |
| Feb 26, 2015 AForm 4 → | Mar 12, 2:25 pm EDT | Bryan M. ReasonsChief Financial Officer | 47,500 | — | — | 47,500 | — | late |
| Feb 26, 2015 AForm 4 → | Mar 12, 2:24 pm EDT | Jeffrey NornholdSVP, Technical Operations | 28,500 | — | — | 28,500 | — | late |
| Feb 26, 2015 AForm 4 → | Mar 12, 2:23 pm EDT | Mark A SchlossbergSVP and General Counsel | 47,500 | — | — | 47,500 | — | late |
| Jan 9, 2015 AForm 4 → | Jan 12, 5:57 pm EST | Leslie Z BenetDirector | 2,750 | — | — | 2,750 | — |